scholarly article | Q13442814 |
P2093 | author name string | Songtao Yang | |
Nan Li | |||
Cuiling Wang | |||
Hualei Wang | |||
Feihu Yan | |||
Xianzhu Xia | |||
Xuexing Zheng | |||
Yongkun Zhao | |||
Yuwei Gao | |||
Hongli Jin | |||
Yuetao Li | |||
Weiwei Gai | |||
Boning Qiu | |||
P2860 | cites work | Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes | Q24673768 |
Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay | Q27488895 | ||
In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes | Q27491029 | ||
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies | Q29619015 | ||
Molecular mechanisms of Ebola pathogenesis. | Q30243891 | ||
Rift valley fever: recent insights into pathogenesis and prevention | Q34174444 | ||
The pathogenesis of Rift Valley fever | Q34191969 | ||
Molecular biology and genetic diversity of Rift Valley fever virus | Q36652695 | ||
Safe pseudovirus-based assay for neutralization antibodies against influenza A(H7N9) virus | Q37262012 | ||
Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry | Q37356916 | ||
From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses | Q38135197 | ||
Avian influenza vaccines against H5N1 'bird flu'. | Q38184763 | ||
IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in domestic ruminants | Q39193651 | ||
Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein | Q39756385 | ||
S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients | Q40551623 | ||
The gerbil, Meriones unguiculatus, a model for Rift Valley fever viral encephalitis | Q40790822 | ||
Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1. | Q45398598 | ||
Development of a safe and rapid neutralization assay using murine leukemia virus pseudotyped with HIV type 1 envelope glycoprotein lacking the cytoplasmic domain | Q45734125 | ||
In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. | Q45864497 | ||
Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection | Q47939183 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Rift Valley fever | Q326638 |
Rift Valley fever virus | Q14276794 | ||
Rift Valley fever phlebovirus | Q24809101 | ||
P304 | page(s) | 200-206 | |
P577 | publication date | 2018-03-01 | |
P1433 | published in | Journal of Veterinary Science | Q6296035 |
P1476 | title | Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method | |
P478 | volume | 19 |
Q89967880 | Immunogenicity Assessment of Rift Valley Fever Virus Virus-Like Particles in BALB/c Mice | cites work | P2860 |
Search more.